-
Loading metrics
Significantly Reduced Genoprevalence of Vaccine-Type HPV-16/18 Infections among Vaccinated Compared to Non-Vaccinated Young Women 5.5 Years after a Bivalent HPV-16/18 Vaccine (Cervarix®) Pilot Project in Uganda
- Edward Kumakech,
- Vanja Berggren,
- Henry Wabinga,
- Gabriella Lillsunde-Larsson,
- Gisela Helenius,
- Malin Kaliff,
- Mats Karlsson,
- Samuel Kirimunda,
- Caroline Musubika,
- Sören Andersson
x
- Published: August 2, 2016
- https://doi.org/10.1371/journal.pone.0160099